Janssen, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc.  
   Our Company
   Innovation & Research
   Commitment - We Will
   Our Products
   Therapy Areas
   Our Giving
   Medical Education
   News Center
Statements
MINDSTORM
MINDSTORM Featured Links
   Contact Us

Get Adobe Reader

Statements

12/22/08 Janssen, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc., Responds to Press Coverage
03/01/07 Janssen, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc., Offers Perspective on CATIE — Phase 1B Results
12/06/06 Janssen, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc., Offers Perspective on CATIE — Cost Effectiveness Analysis Results
04/03/06 Janssen, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc., Offers Perspective on CATIE 2 Results
09/19/05 Statement for Media Regarding CATIE Trial



The National Alliance for Mental Illness (NAMI) "Grading the States" report has significant implications for the millions of people who receive mental health services from state public health systems. By revealing the pervasive gaps, showcasing proven, cost-effective practices from across the nation and offering recommendations for remedial action, NAMI has created a blueprint for advocacy and improvement in care for those with mental illness.

As an organization that shares NAMI's commitment to improving the lives of people living with mental illness, Janssen applauds this effort. Click here to see the full NAMI report.